111![NO 2041 ALK DIRECTION GÉNÉRALE DES FINANCES PUBLIQUES nO #10 NO 2041 ALK DIRECTION GÉNÉRALE DES FINANCES PUBLIQUES nO #10](https://www.pdfsearch.io/img/01e86219f6dd8ab2f98b8635298a648d.jpg) | Add to Reading ListSource URL: www.impots.gouv.frLanguage: French - Date: 2015-04-10 09:54:01
|
---|
112![Allgemeine Verkaufs- und Lieferbedingungen für Arzneimittel der ALK-Abelló Arzneimittel GmbH 1. Allgemeines 1. 1 Mit der Erteilung des Auftrages erkennt der Käufer unsere Allgemeinen Verkaufs- und Lieferbedingun Allgemeine Verkaufs- und Lieferbedingungen für Arzneimittel der ALK-Abelló Arzneimittel GmbH 1. Allgemeines 1. 1 Mit der Erteilung des Auftrages erkennt der Käufer unsere Allgemeinen Verkaufs- und Lieferbedingun](https://www.pdfsearch.io/img/0a76cec8e369c35ea5bdd91fd8655f01.jpg) | Add to Reading ListSource URL: www.milbencheck.atLanguage: German - Date: 2014-10-17 07:14:47
|
---|
113![hydrogen - A Competitive Energy Storage Medium To Enable the Large Scale Integration of Renewable Energies Seville, 15-16 November[removed]H2 from RES: pressurised alk. electrolyser with high efficiency and wide operating hydrogen - A Competitive Energy Storage Medium To Enable the Large Scale Integration of Renewable Energies Seville, 15-16 November[removed]H2 from RES: pressurised alk. electrolyser with high efficiency and wide operating](https://www.pdfsearch.io/img/5930780b93c73bf9572541ebe142f4e6.jpg) | Add to Reading ListSource URL: www.iphe.netLanguage: English - Date: 2012-11-26 15:34:04
|
---|
114![Lung cancer / Organofluorides / Organochlorides / Anatomical pathology / Crizotinib / Pyrazoles / Non-small-cell lung carcinoma / Anaplastic lymphoma kinase / ALK inhibitor / Medicine / Chemistry / Oncology Lung cancer / Organofluorides / Organochlorides / Anatomical pathology / Crizotinib / Pyrazoles / Non-small-cell lung carcinoma / Anaplastic lymphoma kinase / ALK inhibitor / Medicine / Chemistry / Oncology](/pdf-icon.png) | Add to Reading ListSource URL: www.msac.gov.auLanguage: English - Date: 2015-04-16 01:23:53
|
---|
115![Vesalius SCALpel™ : Liver Physiology alk phos from ductal membrane, increased in obstruction fasting glucose from gluconeogenesis from alanine and lactate not from glycolysis Kupfer cells/RES (liver, spleen, lung) clea Vesalius SCALpel™ : Liver Physiology alk phos from ductal membrane, increased in obstruction fasting glucose from gluconeogenesis from alanine and lactate not from glycolysis Kupfer cells/RES (liver, spleen, lung) clea](https://www.pdfsearch.io/img/42f190c9a739eea362eb2c23f314b990.jpg) | Add to Reading ListSource URL: www.vesalius.comLanguage: English - Date: 2009-04-06 14:38:34
|
---|
116![13163 CONCEPT Area A March 2014.indd 13163 CONCEPT Area A March 2014.indd](https://www.pdfsearch.io/img/53854430ad535c9802fce37b5e90ebe5.jpg) | Add to Reading ListSource URL: www.katanning.wa.gov.auLanguage: English - Date: 2014-08-14 03:20:02
|
---|
117![Microsoft Word[removed]FinalPSD-ALKtestingforcrizotinib-Nov2014update-accessible.DOCX Microsoft Word[removed]FinalPSD-ALKtestingforcrizotinib-Nov2014update-accessible.DOCX](https://www.pdfsearch.io/img/512864c80f076a2bec61c0e62aa74b19.jpg) | Add to Reading ListSource URL: www.msac.gov.auLanguage: English - Date: 2015-04-16 01:23:53
|
---|
118![Microsoft Word - ALKsxann[removed]CI ALK Company Update on Solid Progress Microsoft Word - ALKsxann[removed]CI ALK Company Update on Solid Progress](https://www.pdfsearch.io/img/6a08fad6885d3547cfead06f4ea8577f.jpg) | Add to Reading ListSource URL: www.alkane.com.auLanguage: English - Date: 2015-02-11 20:53:22
|
---|
119![ACTIVITY OF THE HSP90 INHIBITOR, AT13387, IN ALK-DRIVEN TUMOR MODELS. Nicola Wallis, Tomoko Smyth, Joanne Munck, Ana Rodriguez-Lopez, Victoria Lock, Rachel McMenamin, Neil Thompson & John Lyons Astex Pharmaceuticals, 436 ACTIVITY OF THE HSP90 INHIBITOR, AT13387, IN ALK-DRIVEN TUMOR MODELS. Nicola Wallis, Tomoko Smyth, Joanne Munck, Ana Rodriguez-Lopez, Victoria Lock, Rachel McMenamin, Neil Thompson & John Lyons Astex Pharmaceuticals, 436](https://www.pdfsearch.io/img/7257ba3b149c37c8b56b7c8dedc3b324.jpg) | Add to Reading ListSource URL: astx.comLanguage: English - Date: 2012-12-17 16:09:22
|
---|
120![THE HSP90 INHIBITOR, AT13387, IS EFFECTIVE IN MUTANT EGFR AND ALK-POSITIVE NSCLC MODELS. Tomoko Smyth, Ana Rodriguez-Lopez, Rachel McMenamin, Victoria Lock, Jayne Curry, Brent Graham, John Lyons, Neil Thompson and Nicola THE HSP90 INHIBITOR, AT13387, IS EFFECTIVE IN MUTANT EGFR AND ALK-POSITIVE NSCLC MODELS. Tomoko Smyth, Ana Rodriguez-Lopez, Rachel McMenamin, Victoria Lock, Jayne Curry, Brent Graham, John Lyons, Neil Thompson and Nicola](https://www.pdfsearch.io/img/ed12eb65fc52f1b8cb35dd6af9301e9b.jpg) | Add to Reading ListSource URL: astx.comLanguage: English |
---|